🔍
Search Results - jinghan+lin
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles
Value Proposition:· Technology creates particles optimally size for use as vehicles for cell transfection.· The reagents and processes for particle creation are kinetically controlled and reproducible.· Cationic particles created using these methods can carry larger payloads than current vehicles.· Reagents and nucleic acid-loaded...
Published: 3/14/2025
|
Inventor(s):
Hai-Quan Mao
,
Yizong Hu
,
Jinghan Lin
Keywords(s):
Category(s):
Technology Classifications > Engineering Tech > Bioreactors
,
Technology Classifications > Engineering Tech > Materials
,
Technology Classifications > Industrial Tech > Bioreactors
,
Technology Classifications > Research Tools > Buffers & Media Solutions
,
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Research Tools > Peptides
,
Technology Classifications > Research Tools > Vectors & Plasmids
,
Technology Classifications > Research Tools > Cell Lines
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Cell Therapies
,
Technology Classifications > Therapeutic Modalities > Peptides
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum